Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04361552 |
|---|---|
| Brief Title: | Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection) |
| First Submitted : | April 7, 2020 |
| First Submitted that Met QC Criteria : | April 22, 2020 |
| First Posted : | April 24, 2020 |
| Last Update Submitted that Met QC Criteria : | June 16, 2020 |
| Last Update Posted : | June 18, 2020 |